Published in Eur Neurol on January 10, 2013
Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol (2013) 3.05
Design and in vivo evaluation of more efficient and selective deep brain stimulation electrodes. J Neural Eng (2015) 0.78
Current Topics in Deep Brain Stimulation for Parkinson Disease. Neurol Med Chir (Tokyo) (2016) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol (2006) 5.49
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (2011) 5.12
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet (2011) 4.52
Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci U S A (2003) 3.96
Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem (2005) 3.87
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol (2007) 3.31
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health (2012) 3.14
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain (2008) 2.65
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg (2009) 2.57
β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40
Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol (2006) 2.18
Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry (2012) 2.15
The health-related quality of life and economic burden of constipation. Pharmacoeconomics (2005) 2.14
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14
Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet (2010) 2.08
Stabilization with the Dynamic Cervical Implant: a novel treatment approach following cervical discectomy and decompression. J Neurosurg Spine (2015) 2.05
Bilateral pallidal stimulation for Wilson's disease. Mov Disord (2013) 1.98
Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics (2007) 1.94
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol (2012) 1.93
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain (2013) 1.93
Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord (2006) 1.89
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord (2007) 1.82
Deep brain stimulation: preoperative issues. Mov Disord (2006) 1.77
Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum. Dev Med Child Neurol (2013) 1.75
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. J Neurosurg (2009) 1.74
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord (2007) 1.72
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome. Int J Infect Dis (2009) 1.67
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A (2007) 1.66
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol (2011) 1.65
Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol (2009) 1.62
Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia. Dev Med Child Neurol (2013) 1.58
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry (2009) 1.57
Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain (2007) 1.56
N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord (2013) 1.55
Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus. Exp Neurol (2012) 1.55
Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia. World Neurosurg (2012) 1.55
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord (2006) 1.54
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry (2012) 1.54
A novel impermeable adhesive membrane to reinforce dural closure: a preliminary retrospective study on 119 consecutive high-risk patients. World Neurosurg (2011) 1.53
Malignant deep brain stimulation-withdrawal syndrome in a patient with Parkinson's disease. Mov Disord (2013) 1.51
Restless legs syndrome in Parkinson's disease. Mov Disord (2009) 1.51
A multi-site study of functional outcomes following a themed approach to hand-arm bimanual intensive therapy for children with hemiplegia. Dev Med Child Neurol (2013) 1.50
Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region. Mov Disord (2010) 1.46
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions. Mov Disord (2013) 1.45
Deep brain stimulation: Subthalamic nucleus electrophysiological activity in awake and anesthetized patients. Clin Neurophysiol (2012) 1.45
Central motor conduction studies and diagnostic magnetic resonance imaging in children with severe primary and secondary dystonia. Dev Med Child Neurol (2011) 1.45
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms. Mov Disord (2008) 1.43
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord (2003) 1.43
The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study. Neuroepidemiology (2013) 1.43
Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording. J Neurol Surg A Cent Eur Neurosurg (2012) 1.42
The causal relationship between subcortical local field potential oscillations and Parkinsonian resting tremor. J Neural Eng (2010) 1.41
Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39
Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A (2006) 1.38
Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases. Acta Neurochir (Wien) (2013) 1.34
Functional analysis of third ventriculostomy patency by quantification of CSF stroke volume by using cine phase-contrast MR imaging. AJNR Am J Neuroradiol (2005) 1.33
Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain (2008) 1.31
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol (2011) 1.30
Long-term outcomes of surgical therapies for Parkinson's disease. Mov Disord (2012) 1.24
Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord (2010) 1.24
Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity. Hum Mol Genet (2004) 1.23
Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology (2006) 1.19
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health (2010) 1.18
The osteo-odonto-keratoprosthesis (OOKP). Semin Ophthalmol (2005) 1.18
Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol (2010) 1.18
Subthalamic local field potentials after seven-year deep brain stimulation in Parkinson's disease. Exp Neurol (2012) 1.17
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord (2002) 1.16
Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol (2006) 1.16
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer (2006) 1.16
Canadian Guidelines on Parkinson's Disease. Can J Neurol Sci (2012) 1.15
Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol (2004) 1.14
Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years. Brain (2013) 1.14
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord (2012) 1.14
Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp (2009) 1.13
Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord (2005) 1.13
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain (2013) 1.12
Subthalamic local field beta oscillations during ongoing deep brain stimulation in Parkinson's disease in hyperacute and chronic phases. Neurosignals (2011) 1.12
Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia (2009) 1.12
Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. J Med Virol (2003) 1.12
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al. AIDS (2007) 1.11
Characteristic head drops and axial extension in advanced chorea-acanthocytosis. Mov Disord (2010) 1.11
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med (2009) 1.10
Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. J Neurophysiol (2007) 1.09
Low-frequency subthalamic nucleus stimulation in Parkinson's disease. Mov Disord (2014) 1.09
The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease. Cereb Cortex (2009) 1.08
Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet (2011) 1.08
The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective. Int J Radiat Oncol Biol Phys (2012) 1.07
A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease. J Neurol (2009) 1.07
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology (2012) 1.07
Neuritis ossificans. J Neurosurg (2014) 1.06
A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. J Med Genet (2013) 1.06
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord (2009) 1.06
SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain (2013) 1.05